Transforming the World's Largest Single-Country Real-World Health Evidence Database into Academic Discoveries and Innovative Research
AI-Powered Research Companion
Techtrials presents EpiWriting, a revolutionary AI-powered research companion designed specifically for academics, graduate students, and healthcare researchers. It optimizes complex analyses, acting as your intelligent partner in discovery.
From Database to Publication-Ready Insights
Built upon the most extensive single-country real-world evidence (RWE) health database, EpiWriting transforms complex hospitalization and epidemiological data into structured, publication-ready insights. This powerful transformation streamlines your data journey.
Accelerating Groundbreaking Discoveries
By delivering clear, actionable insights from vast datasets, EpiWriting significantly accelerates the pace of groundbreaking discoveries in health research. Spend less time on data processing and more on innovative thinking.
Start Your Research Journey

ChatGPT

ChatGPT - EpiWriting Specialist

Helps researchers and healthcare professionals assess viable studies using the EpiWriting databases.

Why EpiWriting?
Health research is often slowed down by fragmented data sources, complex analytical requirements, and the persistent challenges of transforming raw evidence into high-quality, publishable studies. Traditional research workflows can take months or even years to yield significant results, creating bottlenecks in the advancement of medical knowledge and improvements in patient care.
EpiWriting revolutionizes this process by seamlessly combining four crucial research pillars that work together to optimize your entire research workflow, from conception to publication.
World's Largest Real-World Evidence (RWE) Database
Comprehensive coverage in a single country with unprecedented longitudinal depth and scope
Cutting-Edge Custom GPT
Advanced AI technology specifically trained for epidemiological research and analysis
PICOT Methodological Guidance
Structured approach using Population, Intervention, Comparison, Outcome, and Time frameworks
Global Evidence Alignment
Full compliance with NICE, EMA, and other international research standards
With these powerful pillars working in harmony, EpiWriting ensures that your research process becomes faster, methodologically more rigorous, and academically sound, maintaining the highest standards of evidence-based medicine.
Key Capabilities
Data-Driven Study Design
EpiWriting guides you through the comprehensive PICOT framework for your research questions, ensuring methodological rigor from the outset. The system intelligently suggests optimal population subgroups based on age demographics, gender distributions, geographic states, temporal years, and specific medical procedures. This data-driven approach helps researchers identify the most relevant cohorts and design studies that maximize statistical power and clinical relevance.
Advanced Statistical Insights
Our platform performs sophisticated descriptive analyses, comprehensive trend assessments, and robust outcome comparisons across multiple dimensions. EpiWriting automatically generates critical data consistency checks across states, municipalities, and years, while supporting advanced methodologies including time-series analysis, hazard ratios, mortality trends, and length-of-stay assessments. These capabilities ensure your statistical approach meets international publication standards.
Real-World Data Source Integration
The system automatically aligns diverse data streams, including hospitalization records, key performance indicators, and socioeconomic Human Development Index (HDI) indicators for comprehensive analysis. EpiWriting harmonizes complex geographical identifiers to enable precise city and state-level comparisons, while ensuring impeccable data formatting and integrity throughout the analytical pipeline for consistently reliable research outcomes.
Publication-Ready Writing Support
Generate structured, academically rigorous text that seamlessly aligns with RWE frameworks and international journal requirements. EpiWriting assists researchers in crafting comprehensive methods, results, and discussion sections for theses, dissertations, and high-impact journal submissions. The platform provides transparent and fully reproducible workflows that ensure academic credibility and facilitate peer-review processes.
Benefits for Researchers
EpiWriting transforms the traditionally time-consuming research process into an efficient, streamlined workflow that amplifies your research impact while upholding the highest academic standards. Our comprehensive platform addresses every stage of the research journey, from initial question formulation to final manuscript submission.
Save Valuable Time
Accelerate your entire research workflow, from initial question formulation to final manuscript preparation. What traditionally takes months can now be accomplished in weeks, allowing researchers to focus on generating insights rather than grappling with data management and analytical complexities.
Enhance Methodological Rigor
Ensure statistical accuracy and methodological alignment with international best practices and evidence-based standards. Our built-in quality controls and validation procedures guarantee that your research meets the stringent requirements of leading academic journals and funding agencies.
Access Exclusive Data
Leverage Techtrials' unparalleled RWE database, featuring comprehensive coverage of over 10 years of detailed hospitalization records, providing unprecedented depth and longitudinal perspective for your research investigations across multiple disease areas and patient populations.
Focus on Innovation
Dedicate significantly less time to manual data cleaning, preprocessing, and basic analytical tasks, and more energy to generating novel insights, developing innovative hypotheses, and producing groundbreaking research that advances medical knowledge and improves patient care outcomes.
Scalable for Diverse Diseases
Access specialized versions tailored to specific disease areas, including EpiWriting - Dengue, EpiWriting - Breast Cancer, EpiWriting - Alzheimer's and many others. Each version provides disease-specific analytical frameworks, relevant outcome measures, and specialized reporting templates.
Who Should Use EpiWriting?
Academics and Professors
Enhance your teaching effectiveness, optimize student supervision processes, and accelerate the production of high-quality publications. EpiWriting provides the analytical foundation and methodological support needed to effectively guide students while advancing your own research agenda and securing competitive funding for innovative health research projects.
Postgraduate and Doctoral Students
Drastically accelerate dissertation development and thesis completion timelines, ensuring methodological excellence. Our platform offers step-by-step guidance through complex analytical processes, helping students navigate the challenges of large-scale data analysis and produce publication-quality research that advances their academic careers and contributes significantly to medical literature.
Healthcare Researchers
Design, execute, and disseminate RWE studies with demonstrable impact on patient care and health policies. EpiWriting's comprehensive analytical capabilities allow researchers to conduct sophisticated epidemiological studies, evaluate the effectiveness of interventions, and generate evidence that influences clinical practice guidelines and healthcare decision-making at institutional and national levels.
Public Health Specialists
Transform national health data into actionable evidence that informs policy decisions and population health interventions. Our platform enables public health professionals to conduct comprehensive surveillance studies, identify disease patterns and trends, evaluate the effectiveness of public health programs, and generate compelling evidence for resource allocation and strategic health system planning initiatives.
Whether you are conducting exploratory analyses, testing specific hypotheses, or preparing comprehensive systematic reviews, EpiWriting adapts to your unique research needs and methodological preferences, while maintaining consistency with international research standards.
Why Techtrials?
Techtrials stands out as the undisputed national leader in the comprehensive generation of real-world evidence from a single-country perspective, offering researchers unprecedented access to the world's largest and most detailed longitudinal database of hospitalization data. Our extensive database represents more than a decade of meticulously collected, validated, and structured health information.
This unique positioning allows us to provide insights that simply cannot be obtained from fragmented, multinational datasets or smaller-scale studies. The depth and breadth of our single-country coverage enable researchers to conduct sophisticated longitudinal analyses, track disease progression patterns, and evaluate long-term outcomes with exceptional precision and statistical power.
10+
Years of Data
Comprehensive longitudinal coverage, enabling robust trend analyses and outcome evaluation
Mixed Population
Country Coverage
Single-country depth, providing unmatched data consistency and analytical precision with a unique mixed population
150M+
Patient Records
Extensive hospitalization data, enabling large-scale epidemiological investigations
With EpiWriting, this extraordinary data resource is now enhanced with state-of-the-art artificial intelligence capabilities, creating an unprecedented research environment that drives the next generation of evidence-based health research and accelerates the translation of data into actionable medical knowledge.
Our Awards
Techtrials' recognition for excellence in health data analysis and innovation is not merely self-proclaimed; it is endorsed by a series of prestigious awards and distinctions that validate our industry leadership. These honors highlight our unwavering commitment to accuracy, impact, and advancing health research. TOP3 in 100 OpenStartups, KPMG Global Tech Innovator Brazil, Top Healthtech Award Fundação Do Cabral, Distrito Awards, SciBiz 2025 Award, among others.
These awards reflect our dedication to empowering researchers and shaping the future of healthcare through data. We are confident that our successful trajectory and recognition by our peers solidify EpiWriting as an indispensable tool for your research.
Our Strategic Partnerships
At EpiWriting, we believe that collaboration is key to accelerating scientific discovery. We work with leading organizations in research, technology, and healthcare to expand our platform's reach, integrate new technologies, and drive innovative research that transforms global health. Join our growing network of collaborators.
We are always open to new partnerships that help us achieve our mission of democratizing access to real-world evidence-based insights.
Publications - Scientific Validation
Our innovative health data platform has been instrumental in generating a wide range of high-impact scientific research. Discoveries are validated through publications in prestigious journals and in collaboration with leading academic institutions, emphasizing the rigor and credibility of our work.
Scientific Journals
Our studies are published in prestigious journals such as The Lancet, Vaccine, and Journal of Clinical Oncology, attesting to the quality and relevance of our evidence.
Academic Partnerships
We collaborate with institutions like USP, UNICAMP, PUC-Paraná, University of Hong Kong, University of San Diego, University of Calgary, and the Institute of Cancer Research UK, strengthening our global research.
This recognition from the scientific and academic community solidifies Techtrials as a trusted source of real-world evidence.
See EpiWriting in Action
Explore EpiWriting's functionalities and see how it transforms data into scientific discoveries. Our video demonstrates the platform's intuitive process, from data ingestion to the visualization of complex results, showcasing the power of artificial intelligence applied to health research. Below is the ChatGPT version but the webapp will be released soon! PLEASE CHOOSE CAPTIONS IN ENGLISH!
Loading...
Watch to understand how EpiWriting can optimize your research and accelerate the acquisition of crucial insights.
Start Your Research Journey Today
Whether writing your master's thesis, preparing a comprehensive doctoral dissertation, drafting manuscripts for high-impact scientific journals, or exploring complex real-world outcomes for clinical or policy applications, EpiWriting serves as your reliable and intelligent research companion at every stage of the investigative process.
Our platform seamlessly integrates cutting-edge artificial intelligence with the world's most comprehensive real-world evidence database, providing researchers with unparalleled analytical power and methodological support. From initial hypothesis generation to final manuscript preparation, EpiWriting transforms complex health data into compelling, publication-ready insights that advance medical knowledge and improve patient care.
01
Subscribe and Access
Choose your disease-specific EpiWriting product and gain access to our comprehensive research platform and extensive RWE database (Access will be granted and sent to your email within 24 hours of payment approval).
02
Design Your Study
Utilize PICOT methodology and AI-driven recommendations to formulate your research question and optimize study design parameters.
03
Analyze and Generate
Leverage advanced statistical capabilities and automated writing support to produce rigorous analyses and publication-ready manuscripts.
"Transform how you design, analyze, and write your research with the power of AI-enhanced real-world evidence."
Join the growing community of researchers who are revolutionizing health evidence generation with EpiWriting. Experience the future of academic research, where artificial intelligence meets real-world data to accelerate scientific discovery and improve global health outcomes.
Choose and Subscribe Below!
Explore Epiwriting's specialized plans, designed to accelerate your research in specific disease areas. Each plan offers unlimited access to the chosen disease-specific EpiWriting product.
After payment confirmation, you will receive access instructions.
Infectious and Parasitic Diseases
Dengue — A90 and A91
Chikungunya — A92.0
Oropouche Fever — A93.0
COVID-19 (acute phase) — B34.2
Tuberculosis — A15–A19
HIV/AIDS — B20–B24
Malaria — B50–B54
Hepatitis B — B16X, B18.0, B18.1
Hepatitis C — B17.1, B18.2
Syphilis — A50–A53
Leprosy — A30
Chagas Disease — B57, K23.1, K93.1
Visceral Leishmaniasis — B55.0
RSV Infection — B97.4, J12.1, J20.5, J21.0
Chronic and Immunological Diseases
Type 2 Diabetes Mellitus — E11
Obesity — E66
Arterial Hypertension — I10–I15
Acute Myocardial Infarction — I21–I23
Heart Failure — I50
Chronic Kidney Disease — N18
Asthma — J45
Rheumatoid Arthritis — M05–M06
Psoriasis — L40
Atopic Dermatitis — L20
Crohn's Disease — K50
Ulcerative Colitis — K51
Systemic Lupus Erythematosus — M32
Amyloidoses — E85
Oncology and Hematology
Breast Cancer — C50
Prostate Cancer — C61
Lung Cancer (NSCLC) — C34
Colorectal Cancer — C18–C20
Cervical Cancer — C53
Melanoma — C43
Pancreatic Cancer — C25
Liver Cancer — C22
Gastric Cancer — C16
Ovarian Cancer — C56
Multiple Myeloma — C90.0
Diffuse Large B-cell Lymphoma (DLBCL) — C83.3
Sickle Cell Disease — D57
Hemophilia (A/B) — D66–D67
Neurological and Musculoskeletal Diseases
Alzheimer's Disease — G30
Parkinson's Disease — G20
Multiple Sclerosis — G35
Epilepsy — G40–G41
Migraine — G43
Spinal Muscular Atrophy (SMA) — G12
Muscular Dystrophy — G71.0
Each edition leverages the power of real-world evidence and advanced analytics to support your research, from hypothesis generation to publication. Select the relevant edition for your field and start your innovative work today.
EpiWriting is a Techtrials product: www.ttrials.com
To cancel your subscription, please send a message to: epiwriting@ttrials.com